Fredun Pharmaceuticals Ltd. is an India-based pharmaceuticals formulation manufacturing company. The Company is engaged in manufacturing dietary/herbal supplements, nutraceuticals, and other healthcare products, along with animal healthcare products. Its segment includes Fredun Generics, Pet Care, Nutraceuticals, Cosmeceuticals and Mobility. Its Generics Division, marketed under the Fredun Gx brand. The Pet Healthcare segment operates under the Freossi brand. The Nutraceutical Division under Fredun Nutrition brand. Its Cosmeceuticals Division, operating under the Bird N Beauty (BNB) and Beautyfred brands, is focused on skincare and personal care products. Its Mobility Division, operating under Chuu Balm, BraceOn, NebOn, and DigiOn, caters to the ortho rehabilitation aids and pain management market. It offers a range of products, including antihypertensive, antidiabetic, antiretroviral drugs (ARVs) and narcotics. It also provides comprehensive pet care technology platforms.As of 26 May 2026, Fredun Pharmaceuticals Limited share price is ₹2,384.10. The stock opened at ₹2,573.00, compared to its previous close of ₹2,528.85. During today's trading session, Fredun Pharmaceuticals Limited share price moved in the range of ₹2,250.00 to ₹2,620.00, with an average price of ₹2,435.00 for the day. Looking at its last 52-week, the stock has touched a low of ₹2,250.00 and a high of ₹2,620.00.
The market capitalization of Fredun Pharmaceuticals Limited is ₹1,394 Crs, with a P/E ratio of 42.7 and a dividend yield of 0.02%.